Nitazene Control Act

S 3076, the Nitazene Control Act, permanently classifies nitazenes and related 2-benzylbenzimidazole opioids as Schedule I controlled substances under the federal Controlled Substances Act. This affects anyone possessing, distributing, or researching these substances, as it bans them without specific exemptions. The bill broadly defines the prohibited substances to cover all structural analogs (including modifications to the molecular structure) and those that activate the mu-opioid receptor. It also removes temporary scheduling for these compounds, making their Schedule I status permanent upon enactment. This policy change aims to prevent new illicit analogs from entering the drug supply and reduce overdose risks linked to these potent synthetic opioids.